Skip to main content
. Author manuscript; available in PMC: 2017 Mar 25.
Published in final edited form as: Kidney Blood Press Res. 2016 Mar 25;41(2):208–221. doi: 10.1159/000443424

Table 1.

Effects of MSU i.r. infusion on renal function in mice receiving vehicle and caspase-1 inhibitor

Control 0.1 0.3 0.6 Post
U•V Vehl 14.60±0.47 9.82±1.56 6.58±2.00* 4.65±1.79* 5.28±2.30*
(µl/min/gkw) YVAD 15.80±1.34 14.91±1.75 14.27±1.66 12.10±1.50 12.72±1.40
UNa•V Vehl 3.87±0.31 2.59±0.34 1.64±0.47* 1.17±0.41* 1.39±0.39*
(µmol/min/gkw) YVAD 4.01±0.39 3.65±0.26 3.55±0.28 2.97±0.39 3.40±0.46
UK•V Vehl 1.61±0.32 1.42±0.19 1.41±0.20 1.39±0.21 1.52±0.19
(µmol/min/gkw) YVAD 1.50±0.11 1.53±0.11 1.49±0.09 1.45±0.08 1.48±0.11

U•V: urine volume, UNa•V; urinary sodium excretion, UK•V; urinary potassium excretion. Values are arithmetic means ± SEM (n=6 mice per group),

*

P<0.05 vs. control periods.